Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis

Authors:: Xiaogang Li; Chao Niu; Guoqiang Yi; Yuan Zhang; Wendi Jin; Zhiping Zhang; Wanfu Zhang; Bo Li

Reference:: PLoS ONE; 2024; 19; e0305612

DOI:: 10.1371/journal.pone.0305612

See Abstract

Key Words:: Breast cancer; MCF-7; MDA-MB-231; epithelial mesenchymal transition; circHIAT1/miR-19a-3p/CADM2; quercetin; palbociclib; mice; animal experiments

Back to index